Der Einfluss des Hämoglobinwertes auf die hämatogene Tumorzelldisseminierung zum Zeitpunkt der Primärdiagnose des Mammakarzinoms

Hintergrund und Fragestellung: Patienten und Methodik: Ergebnisse: Folgerung: Background and objective: Patients and methods: Results: Conclusion:

[1]  S. Braun,et al.  The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence , 2001, Cancer.

[2]  J. Caro,et al.  Anemia as an independent prognostic factor for survival in patients with cancer , 2001 .

[3]  A. Erslev.  Erythropoietin and anemia of cancer , 2000, European journal of haematology.

[4]  T. Dimpfl,et al.  Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. , 2000, The New England journal of medicine.

[5]  J. Crook,et al.  The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix , 1999, Cancer.

[6]  Ş. Yalçın,et al.  What are cancer patients willing to pay for prophylactic epoetin alfa?—A cost‐benefit analysis , 1999, Cancer.

[7]  D J Ferguson,et al.  Dormancy of mammary carcinoma after mastectomy. , 1999, Journal of the National Cancer Institute.

[8]  J. Adamson,et al.  Predicting the Hematopoietic Response to Recombinant Human Erythropoietin (Epoetin Alfa) in the Treatment of the Anemia of Cancer , 1999, Oncology.

[9]  B. Vikram,et al.  Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27. , 1998, International journal of radiation oncology, biology, physics.

[10]  C. Manegold.  The causes and prognostic significance of low hemoglobin levels in tumor patients. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[11]  A. Kaider,et al.  The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients , 1998, Cancer.

[12]  H. Ludwig,et al.  Anemia in cancer patients. , 1998, Seminars in oncology.

[13]  A. van Dalen,et al.  Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 Workshop , 1998, Tumor Biology.

[14]  E. Jaffee,et al.  Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines. , 1997, Methods.

[15]  A. Dowlati,et al.  Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production , 1997, British journal of haematology.

[16]  P. Giraud,et al.  Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study. , 1996, Radiology.

[17]  P. Vaupel,et al.  Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. , 1996, Cancer research.

[18]  J. Kvasnička,et al.  [Treatment of anemia in patients with tumors]. , 1995, Casopis lekaru ceskych.

[19]  W. Curran,et al.  Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  H. Ludwig,et al.  Recombinant Human Erythropoietin , 1989 .

[21]  C. Scheibenbogen,et al.  Hematogenous spread of malignant melanoma cells in different stages of disease. , 1993, The Journal of investigative dermatology.

[22]  J. Crowley,et al.  Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Goldberg,et al.  Erythropoietin therapy in cancer patients. , 1991, Oncology.

[24]  D. Derienzo,et al.  Anemia of chronic disease: a review of pathogenesis. , 1990, Texas medicine.

[25]  S. Piantadosi,et al.  Decreased erythropoietin response in patients with the anemia of cancer. , 1990, The New England journal of medicine.

[26]  J. Sørensen,et al.  Prognostic factors in inoperable adenocarcinoma of the lung: a multivariate regression analysis of 259 patients. , 1988, Cancer research.

[27]  R. Bush.  The significance of anemia in clinical radiation therapy. , 1986, International journal of radiation oncology, biology, physics.

[28]  P. Andersen,et al.  Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. , 1986, Cancer research.

[29]  H Stein,et al.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). , 1984, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  H. Ludwig.  Epoetin in cancer-related anaemia. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  D. Schultz,et al.  Significance of pretreatment hemoglobin level in patients with T1 glottic cancer. , 1999, Radiation oncology investigations.

[32]  L. Sobin.  Frequently asked questions regarding the application of the TNM classification. TNM/Prognostic Factors Project (International Union Against Cancer [UICC]). , 1999, Cancer.

[33]  W. Jelkmann,et al.  Inhibition of erythropoietin production by cytokines and chemotherapy may contribute to the anemia in malignant diseases. , 1994, Advances in experimental medicine and biology.

[34]  K. Pantel,et al.  Detection and characterization of residual disease in breast cancer. , 1994, Journal of hematotherapy.

[35]  W. Jelkmann,et al.  Inhibition of erythropoietin production by cytokines. Implications for the anemia involved in inflammatory states. , 1994, Annals of the New York Academy of Sciences.

[36]  B. Shohat,et al.  The influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma. , 1992, Panminerva medica.

[37]  B. Sorbe,et al.  Fever, haemoglobin and smoking as prognostic factors during the treatment of cervical carcinoma by radiotherapy. , 1990, European journal of gynaecological oncology.

[38]  T. Poskitt.  Radiation therapy and the role of red blood cell transfusion. , 1987, Cancer investigation.

[39]  P. Vaupel,et al.  Cell line and growth site as relevant parameters governing tumor tissue oxygenation. , 1986, Advances in experimental medicine and biology.

[40]  G. R. Lee,et al.  The anaemia of chronic disorders. , 1971, British journal of haematology.